References
- Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services – Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1–5. doi: 10.1016/j.jsat.2017.05.007
- Englander H, Davis CS. Hospital standards of care for people with substance use disorder. N Engl J Med. 2022;387(8):672–675. doi: 10.1056/NEJMp2204687
- Wakeman SE, Metlay JP, Chang Y, et al. InpatienT addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909–916. doi: 10.1007/s11606-017-4077-z
- Wakeman SE, Kane M, Powell E, et al. Impact of inpatient addiction consultation on hospital readmission. J Gen Intern Med. 2021;36(7):2161–2163. doi: 10.1007/s11606-020-05966-0
- Englander H, Dobbertin K, Lind BK, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796–2803. doi: 10.1007/s11606-019-05251-9
- Marks LR, Munigala S, Warren DK, et al. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;68(11):1935–1937. doi: 10.1093/cid/ciy924
- American Board of Preventive Medicine. Addiction medicine requirements table. Published 2023. Accessed Mar 7, 2023. https://www.theabpm.org/become-certified/subspecialties/addiction-medicine/table/
- Shanafelt TD, West CP, Dyrbye LN, et al. Changes in burnout and satisfaction with work-life integration in physicians during the first 2 years of the COVID-19 Pandemic. Mayo Clin Proc. 2022;97(12):2248–2258. doi: 10.1016/j.mayocp.2022.09.002
- Linzer M, Poplau S. Eliminating burnout and moral injury: bolder steps required. EClinicalMedicine. 2021;39:101090. doi: 10.1016/j.eclinm.2021.101090
- Shanafelt TD, Noseworthy JH. Executive leadership and physician well-being: nine organizational strategies to promote engagement and reduce burnout. Mayo Clin Proc. 2017;92(1):129–146. doi: 10.1016/j.mayocp.2016.10.004
- Accreditation Council for Graduate Medical Education (ACGME)ACGME program requirements for graduate medical education in internal medicine202271Accessed Mar 7, 2023https://www.acgme.org/globalassets/pfassets/programrequirements/140_internalmedicine_2022v4.pdf
- American Trauma Society. Trauma center levels explained. Accessed Mar 7, 2023. https://www.amtrauma.org/page/traumalevels
- Colorado Department of Health Care Policy & Financing. Colorado hospital transformation program. Published 2023. Accessed Mar 7, 2023. https://hcpf.colorado.gov/colorado-hospital-transformation-program
- Colorado Dept Health Care Policy & Financing. Regional accountable entity behavioral health incentive specification document. SFY 2022-2023. 2022. 34. Accessed Mar 17, 2023. https://hcpf.colorado.gov/sites/hcpf/files/Behavioral%20Health%20Incentive%20Specification%20Document%20SFY22-23.pdf
- Centers for Medicare & Medicaid Services. HCAHPS: patients’ perspectives of care survey. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/HospitalHCAHPS
- Kosanke N, Magura S, Staines G, et al. Feasibility of matching alcohol patients to ASAM levels of care. Am J Addict. 2002;11(2):124–134. doi: 10.1080/10550490290087893
- Collins SE, Duncan MH, Saxon AJ, et al. Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial. Lancet Psychiatry. 2021;8(4):287–300. doi: 10.1016/S2215-0366(20)30489-2
- Drummond C, Gilburt H, Burns T, et al. Assertive community treatment for people with alcohol dependence: a pilot randomized controlled trial. Alcohol Oxf Oxfs. 2017;52(2):234–241. doi: 10.1093/alcalc/agw091
- Gryczynski J, Nordeck CD, Welsh C, et al. Preventing hospital readmission for patients with comorbid substance use disorder: a randomized trial. Ann Intern Med. 2021;174(7):899–909. doi: 10.7326/M20-5475
- Terasaki D, Loh R, Cornell A, et al. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022;17(1):64. doi: 10.1186/s13722-022-00345-y
- Center for Medicare & Medicaid Services. The mental health parity and addiction equity act (MHPAEA). Accessed Apr 12, 2023. https://www.cms.gov/CCIIO/Programs-and-Initiatives/Other-Insurance-Protections/mhpaea_factsheet